{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:55:38Z","timestamp":1787496938107,"version":"build-2736575974"},"reference-count":161,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.hfc.2012.04.002","type":"journal-article","created":{"date-parts":[[2012,6,30]],"date-time":"2012-06-30T01:33:57Z","timestamp":1341020037000},"page":"427-445","source":"Crossref","is-referenced-by-count":13,"title":["Congenital Heart Disease and Pulmonary Hypertension"],"prefix":"10.1016","volume":"8","author":[{"given":"Vedant","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano R.","family":"Tonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Krasuski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hfc.2012.04.002_bib1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1136\/bmj.2.5099.755","article-title":"The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt","volume":"2","author":"Wood","year":"1958","journal-title":"Br Med J"},{"key":"10.1016\/j.hfc.2012.04.002_bib2","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1161\/01.CIR.76.5.1037","article-title":"Isolated atrial septal defect with pulmonary vascular obstructive disease\u2013long-term follow-up and prediction of outcome after surgical correction","volume":"76","author":"Steele","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2012.04.002_bib3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/hrt.20.4.529","article-title":"Pulmonary hypertension in congenital heart disease","volume":"20","author":"Evans","year":"1958","journal-title":"Br Heart J"},{"key":"10.1016\/j.hfc.2012.04.002_bib4","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/0002-8703(83)90396-4","article-title":"Pulmonary hypertension in isolated secundum atrial septal defect: high frequency in young patients","volume":"105","author":"Cherian","year":"1983","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2012.04.002_bib5","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0002-9149(86)90623-5","article-title":"Pulmonary vascular bed in children with complete atrioventricular septal defect: relation between structural and hemodynamic abnormalities","volume":"57","author":"Haworth","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib6","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0002-9149(77)80135-5","article-title":"Pulmonary vascular disease in complete atrioventricular canal defect","volume":"39","author":"Newfeld","year":"1977","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/hrt.33.2.246","article-title":"Natural history of ventricular septal defect","volume":"33","author":"Campbell","year":"1971","journal-title":"Br Heart J"},{"key":"10.1016\/j.hfc.2012.04.002_bib8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM199207093270202","article-title":"An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension","volume":"327","author":"Christman","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2012.04.002_bib9","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/01.CIR.18.4.533","article-title":"The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects","volume":"18","author":"Heath","year":"1958","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2012.04.002_bib10","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1161\/01.CIR.58.6.1107","article-title":"Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease","volume":"58","author":"Rabinovitch","year":"1978","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2012.04.002_bib11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1161\/01.CIR.69.4.655","article-title":"Vascular structure in lung tissue obtained at biopsy correlated with pulmonary hemodynamic findings after repair of congenital heart defects","volume":"69","author":"Rabinovitch","year":"1984","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2012.04.002_bib12","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/hrt.23.5.587","article-title":"Atrial septal defect with pulmonary hypertension","volume":"23","author":"Besterman","year":"1961","journal-title":"Br Heart J"},{"key":"10.1016\/j.hfc.2012.04.002_bib13","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/CIRCULATIONAHA.105.592386","article-title":"Pulmonary vascular disease in adults with congenital heart disease","volume":"115","author":"Diller","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2012.04.002_bib14","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1152\/jappl.1994.77.2.867","article-title":"Pulmonary hypertension and arterial changes in calves with a systemic-to-left pulmonary artery connection","volume":"77","author":"Fasules","year":"1994","journal-title":"J\u00a0Appl Physiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib15","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/0002-9149(65)90047-0","article-title":"The natural history of ventricular septal defects in infancy","volume":"16","author":"Hoffman","year":"1965","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib16","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/j.jacc.2004.02.029","article-title":"Cellular and molecular pathobiology of pulmonary arterial hypertension","volume":"43","author":"Humbert","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib17","first-page":"I38","article-title":"Second natural history study of congenital heart defects. Results of treatment of patients with ventricular septal defects","volume":"87","author":"Kidd","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2012.04.002_bib18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0735-1097(99)00153-9","article-title":"Eisenmenger syndrome in adults: ventricular septal defect, truncus arteriosus, univentricular heart","volume":"34","author":"Niwa","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib19","doi-asserted-by":"crossref","first-page":"745","DOI":"10.7326\/0003-4819-128-9-199805010-00008","article-title":"The Eisenmenger syndrome in adults","volume":"128","author":"Vongpatanasin","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hfc.2012.04.002_bib20","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.104.529800","article-title":"Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication","volume":"112","author":"Diller","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2012.04.002_bib21","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.jacc.2009.04.011","article-title":"Diagnosis and assessment of pulmonary arterial hypertension","volume":"54","author":"Badesch","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib22","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"Galie","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2012.04.002_bib23","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib24","doi-asserted-by":"crossref","first-page":"52S","DOI":"10.1378\/chest.09-2861","article-title":"Pulmonary hypertension associated with congenital heart disease: pulmonary vascular disease: the global perspective","volume":"137","author":"Adatia","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.hfc.2012.04.002_bib25","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1136\/hrt.2004.039198","article-title":"Massive pulmonary artery thrombosis with haemoptysis in adults with Eisenmenger's syndrome: a clinical dilemma","volume":"90","author":"Broberg","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.hfc.2012.04.002_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00019501-200502000-00004","article-title":"The remarkable right ventricle of patients with Eisenmenger syndrome","volume":"16","author":"Hopkins","year":"2005","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.hfc.2012.04.002_bib27","first-page":"100","article-title":"Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome","volume":"15","author":"Hopkins","year":"1996","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.hfc.2012.04.002_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1017\/S1047951107001849","article-title":"Pulmonary arterial hypertension in congenital cardiac disease\u2013the need for refinement of the Evian-Venice classification","volume":"18","author":"van Albada","year":"2008","journal-title":"Cardiol Young"},{"key":"10.1016\/j.hfc.2012.04.002_bib29","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/HCO.0b013e3283126954","article-title":"Pulmonary arterial hypertension in adults with congenital heart disease: distinct differences from other causes of pulmonary arterial hypertension and management implications","volume":"23","author":"Dimopoulos","year":"2008","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib30","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jacc.2008.11.025","article-title":"Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension","volume":"53","author":"Beghetti","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/CIRCULATIONAHA.106.627224","article-title":"Congenital heart disease in the general population: changing prevalence and age distribution","volume":"115","author":"Marelli","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2012.04.002_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2008.08.029","article-title":"Planning the specialized care of adult congenital heart\u00a0disease patients: from numbers to guidelines; an epidemiologic approach","volume":"157","author":"Marelli","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2012.04.002_bib33","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/hrt.2006.098848","article-title":"Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease","volume":"93","author":"Engelfriet","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.hfc.2012.04.002_bib34","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1203\/00006450-198609000-00001","article-title":"Proceedings of National Heart, Lung, and Blood Institute pediatric cardiology workshop: pulmonary hypertension","volume":"20","author":"Friedman","year":"1986","journal-title":"Pediatr Res"},{"key":"10.1016\/j.hfc.2012.04.002_bib35","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijcard.2006.09.017","article-title":"Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry","volume":"120","author":"Duffels","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib36","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jacc.2011.03.033","article-title":"Diagnosis of pulmonary hypertension in the congenital heart disease adult population impact on outcomes","volume":"58","author":"Lowe","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib37","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S1053-2498(99)00015-7","article-title":"Pulmonary hypertension: pathophysiology as a basis for clinical decision making","volume":"18","author":"Rabinovitch","year":"1999","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.hfc.2012.04.002_bib38","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1056\/NEJMoa021650","article-title":"Signaling molecules in nonfamilial pulmonary hypertension","volume":"348","author":"Du","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2012.04.002_bib39","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1161\/CIRCULATIONAHA.108.769646","article-title":"Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension","volume":"117","author":"Diller","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2012.04.002_bib40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1161\/01.CIR.34.1.127","article-title":"Incidence of bacterial endocarditis in ventricular septal defects","volume":"34","author":"Shah","year":"1966","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2012.04.002_bib41","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ijcard.2008.10.025","article-title":"The BNP concentrations and exercise capacity assessment with cardiopulmonary stress test in cyanotic adult patients with congenital heart diseases","volume":"139","author":"Trojnarska","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib42","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1053\/pcad.2002.127492","article-title":"Eisenmenger's syndrome: current management","volume":"45","author":"Berman","year":"2002","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.hfc.2012.04.002_bib43","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3181\/00379727-199-43342","article-title":"Endothelin 1: mitogenic activity on pulmonary artery smooth muscle cells and release from hypoxic endothelial cells","volume":"199","author":"Hassoun","year":"1992","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.hfc.2012.04.002_bib44","first-page":"L101","article-title":"Overexpression of endothelin-1 and enhanced growth of pulmonary artery smooth muscle cells from fawn-hooded rats","volume":"270","author":"Zamora","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib45","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0002-9149(93)90452-I","article-title":"Endothelin-1 in primary pulmonary hypertension and the Eisenmenger syndrome","volume":"71","author":"Cacoub","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib46","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJM199507273330403","article-title":"Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension","volume":"333","author":"Giaid","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2012.04.002_bib47","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/01.CIR.93.2.266","article-title":"Role of nitric oxide in the local regulation of pulmonary vascular resistance in humans","volume":"93","author":"Cooper","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2012.04.002_bib48","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJM199312303292706","article-title":"The L-arginine-nitric oxide pathway","volume":"329","author":"Moncada","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2012.04.002_bib49","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1161\/01.CIR.0000099502.17776.C2","article-title":"Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension","volume":"108","author":"Michelakis","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2012.04.002_bib50","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1161\/01.CIR.0000143836.40431.F5","article-title":"Signaling molecules in overcirculation-induced pulmonary hypertension in piglets: effects of sildenafil therapy","volume":"110","author":"Rondelet","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2012.04.002_bib51","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1164\/ajrccm.159.6.9804054","article-title":"Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension","volume":"159","author":"Tuder","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hfc.2012.04.002_bib52","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1183\/09031936.04.00018604","article-title":"BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease","volume":"24","author":"Roberts","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hfc.2012.04.002_bib53","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1161\/01.CIR.0000132476.87231.6F","article-title":"Pulmonary arterial hypertension: future directions: report of a National Heart, Lung and Blood Institute\/Office of Rare Diseases workshop","volume":"109","author":"Newman","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2012.04.002_bib54","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1183\/09031936.05.00072504","article-title":"Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension","volume":"25","author":"Lepetit","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hfc.2012.04.002_bib55","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI17500","article-title":"Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension","volume":"111","author":"Petkov","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.hfc.2012.04.002_bib56","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1161\/01.RES.0000222546.45372.a0","article-title":"Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension","volume":"98","author":"Guignabert","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.hfc.2012.04.002_bib57","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1164\/rccm.200707-1083OC","article-title":"Role of the TGF-beta\/Alk5 signaling pathway in monocrotaline-induced pulmonary hypertension","volume":"177","author":"Zaiman","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hfc.2012.04.002_bib58","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jacc.2009.04.018","article-title":"Cellular and molecular basis of pulmonary arterial hypertension","volume":"54","author":"Morrell","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib59","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1164\/rccm.201006-0869WS","article-title":"Strategic plan for lung vascular research: an NHLBI-ORDR Workshop Report","volume":"182","author":"Erzurum","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hfc.2012.04.002_bib60","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1093\/eurheartj\/ehl116","article-title":"Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study","volume":"27","author":"Diller","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2012.04.002_bib61","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1161\/CIRCULATIONAHA.105.594218","article-title":"Abnormal ventilatory response to exercise in adults with congenital heart disease relates to cyanosis and predicts survival","volume":"113","author":"Dimopoulos","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2012.04.002_bib62","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1183\/09031936.01.17406470","article-title":"Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension","volume":"17","author":"Paciocco","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hfc.2012.04.002_bib63","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1164\/ajrccm.161.2.9906015","article-title":"Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing","volume":"161","author":"Miyamoto","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hfc.2012.04.002_bib64","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/01.CIR.0000022687.18568.2A","article-title":"Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing","volume":"106","author":"Wensel","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2012.04.002_bib65","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0002-9149(99)00415-4","article-title":"Determinants of survival and length of survival in adults with Eisenmenger syndrome","volume":"84","author":"Cantor","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib66","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1053\/euhj.1998.1046","article-title":"Eisenmenger syndrome. Factors relating to deterioration and death","volume":"19","author":"Daliento","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2012.04.002_bib67","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1093\/eurheartj\/ehi823","article-title":"Eisenmenger syndrome: towards identifying the risk factors for death","volume":"27","author":"Sreeram","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2012.04.002_bib68","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jacc.2007.04.056","article-title":"Pulmonary arterial thrombosis in eisenmenger syndrome is associated with biventricular dysfunction and decreased pulmonary flow velocity","volume":"50","author":"Broberg","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib69","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2003.07.022","article-title":"Pulmonary thrombosis in adults with Eisenmenger syndrome","volume":"42","author":"Silversides","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib70","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jacc.2006.03.040","article-title":"Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease","volume":"48","author":"Broberg","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib71","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0002-8703(88)90260-8","article-title":"Erythropoietin in cyanotic heart disease","volume":"116","author":"Gidding","year":"1988","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2012.04.002_bib72","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0022-3476(70)80165-2","article-title":"Hyperviscosity in congenital heart disease","volume":"76","author":"Kontras","year":"1970","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.hfc.2012.04.002_bib73","doi-asserted-by":"crossref","first-page":"406","DOI":"10.7326\/0003-4819-109-5-406","article-title":"Adults with cyanotic congenital heart disease: hematologic management","volume":"109","author":"Perloff","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hfc.2012.04.002_bib74","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0140-6736(86)90005-X","article-title":"Chronic hypoxaemia and decompensated erythrocytosis in cyanotic congenital heart disease","volume":"2","author":"Rosove","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2012.04.002_bib75","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.amjcard.2006.01.083","article-title":"Pathogenesis of thrombocytopenia in cyanotic congenital heart disease","volume":"98","author":"Lill","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib76","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0733-8651(18)30147-4","article-title":"Systemic complications of cyanosis in adults with congenital heart disease. Hematologic derangements, renal function, and urate metabolism","volume":"11","author":"Perloff","year":"1993","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.hfc.2012.04.002_bib77","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/0735-1097(96)00196-9","article-title":"Cerebrovascular events in adult patients with cyanotic congenital heart disease","volume":"28","author":"Ammash","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib78","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0002-9149(00)01202-9","article-title":"Pathogenesis of\u00a0the glomerular abnormality in cyanotic congenital heart disease","volume":"86","author":"Perloff","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib79","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1161\/01.CIR.87.6.1954","article-title":"Risk of stroke in adults with cyanotic congenital heart disease","volume":"87","author":"Perloff","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2012.04.002_bib80","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.amjcard.2004.06.014","article-title":"Erythrocyte indexes, iron metabolism, and hyperhomocysteinemia in adults with cyanotic congenital cardiac disease","volume":"94","author":"Kaemmerer","year":"2004","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.hfc.2012.04.002_bib81","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/heartjnl-2011-301522","article-title":"B type natriuretic peptide concentrations in contemporary Eisenmenger syndrome patients: predictive value and response to disease targeting therapy","volume":"98","author":"Diller","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.hfc.2012.04.002_bib82","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1651-2227.2011.02258.x","article-title":"Plasma B-type natriuretic peptide levels in children\u00a0with heart disease","volume":"100","author":"Knirsch","year":"2011","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.hfc.2012.04.002_bib83","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1161\/CIRCULATIONAHA.104.509869","article-title":"Pulmonary neovascularity: a distinctive radiographic finding in Eisenmenger syndrome","volume":"112","author":"Sheehan","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2012.04.002_bib84","doi-asserted-by":"crossref","first-page":"e714","DOI":"10.1161\/CIRCULATIONAHA.108.190690","volume":"118","author":"Warnes","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2012.04.002_bib85","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/CIRCULATIONAHA.109.192230","volume":"119","author":"McLaughlin","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2012.04.002_bib86","doi-asserted-by":"crossref","first-page":"I76","DOI":"10.1161\/01.cir.0000032875.55215.cb","article-title":"Inhaled nitric oxide as a preoperative test (INOP test I): the INOP Test Study Group","volume":"106","author":"Balzer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2012.04.002_bib87","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.ehj.2004.07.005","article-title":"Responsiveness to inhaled nitric oxide is a predictor for mid-term survival in adult patients with congenital heart defects and pulmonary arterial hypertension","volume":"25","author":"Post","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2012.04.002_bib88","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1136\/hrt.2010.199661","article-title":"Pulmonary vasoreactivity predicts long-term outcome in patients with Eisenmenger syndrome receiving bosentan therapy","volume":"96","author":"D'Alto","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.hfc.2012.04.002_bib89","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/heart.86.5.553","article-title":"Residual pulmonary vasoreactivity to inhaled nitric oxide in patients with severe obstructive pulmonary hypertension and Eisenmenger syndrome","volume":"86","author":"Budts","year":"2001","journal-title":"Heart"},{"key":"10.1016\/j.hfc.2012.04.002_bib90","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0002-9378(99)70151-1","article-title":"Favorable response of Eisenmenger syndrome to inhaled nitric oxide during pregnancy","volume":"180","author":"Goodwin","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.hfc.2012.04.002_bib91","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hfc.2012.04.002_bib92","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2165\/00003495-200868080-00004","article-title":"Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome","volume":"68","author":"Galie","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.hfc.2012.04.002_bib93","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0195-668X(03)00131-3","article-title":"Management of grown up congenital heart disease","volume":"24","author":"Deanfield","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2012.04.002_bib94","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0140-6736(90)90549-K","article-title":"Antibiotic prophylaxis of infective endocarditis. Recommendations from the Endocarditis Working Party of the British Society for Antimicrobial Chemotherapy","volume":"335","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2012.04.002_bib95","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1161\/CIRCULATIONAHA.106.183095","article-title":"Prevention of infective endocarditis: guidelines from the American Heart Association","volume":"116","author":"Wilson","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2012.04.002_bib96","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1093\/eurheartj\/ehq170","article-title":"Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension","volume":"31","author":"Montani","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2012.04.002_bib97","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/oxfordjournals.eurheartj.a060936","article-title":"Maternal and fetal outcome in pregnant women with Eisenmenger's syndrome","volume":"16","author":"Avila","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2012.04.002_bib98","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/bmj.38756.482882.DE","article-title":"Pregnancy and congenital heart disease","volume":"332","author":"Uebing","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.hfc.2012.04.002_bib99","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1471-0528.1998.tb10240.x","article-title":"Eisenmenger's syndrome in pregnancy: maternal and fetal mortality in the 1990s","volume":"105","author":"Yentis","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.hfc.2012.04.002_bib100","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/heartjnl-2011-300828","article-title":"Maternal cardiovascular events during childbirth among women with congenital heart disease","volume":"98","author":"Opotowsky","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.hfc.2012.04.002_bib101","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/hrt.2004.051961","article-title":"Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease","volume":"91","author":"Apostolopoulou","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.hfc.2012.04.002_bib102","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1378\/chest.129.4.1009","article-title":"Efficacy of bosentan in a small cohort of adult patients with pulmonary arterial hypertension related to congenital heart disease","volume":"129","author":"Benza","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.hfc.2012.04.002_bib103","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(01)06250-X","article-title":"Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study","volume":"358","author":"Channick","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2012.04.002_bib104","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.amjcard.2004.03.081","article-title":"Initial experience with bosentan therapy in patients with the Eisenmenger syndrome","volume":"94","author":"Christensen","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib105","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijcard.2004.08.025","article-title":"Safety and tolerability of bosentan in adults with Eisenmenger physiology","volume":"98","author":"Gatzoulis","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib106","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s00392-005-0266-6","article-title":"Initial experience with bosentan (Tracleer) as treatment for pulmonary arterial hypertension (PAH) due to congenital heart disease in infants and young children","volume":"94","author":"Gilbert","year":"2005","journal-title":"Z\u00a0Kardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib107","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2012.04.002_bib108","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.ahj.2005.07.005","article-title":"Adult patients with congenital heart disease and pulmonary arterial hypertension: first open prospective multicenter study of bosentan therapy","volume":"150","author":"Schulze-Neick","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2012.04.002_bib109","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.106.630715","article-title":"Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study","volume":"114","author":"Galie","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2012.04.002_bib110","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ijcard.2009.04.037","article-title":"Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysis","volume":"144","author":"Berger","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib111","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijcard.2007.04.078","article-title":"Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study","volume":"127","author":"Gatzoulis","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib112","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/hrt.2006.100388","article-title":"Long-term oral bosentan treatment in patients with pulmonary arterial hypertension related to congenital heart disease: a 2-year study","volume":"93","author":"Apostolopoulou","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.hfc.2012.04.002_bib113","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1136\/hrt.2006.097360","article-title":"Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): safety, tolerability, clinical, and haemodynamic effect","volume":"93","author":"D'Alto","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.hfc.2012.04.002_bib114","first-page":"1046","article-title":"Long-term bosentan treatment of complex congenital heart disease and Eisenmenger's syndrome","volume":"62","author":"Diaz-Caraballo","year":"2009","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib115","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/hrt.2006.089185","article-title":"Long-term safety, tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease","volume":"93","author":"Diller","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.hfc.2012.04.002_bib116","first-page":"256","article-title":"Endothelin receptor antagonists improve exercise tolerance and oxygen saturations in patients with Eisenmenger syndrome and congenital heart defects","volume":"35","author":"Mehta","year":"2008","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.hfc.2012.04.002_bib117","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(08)60919-8","article-title":"Treatment of\u00a0patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial","volume":"371","author":"Galie","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2012.04.002_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2011.06.064","article-title":"Prolonged beneficial effect of bosentan treatment and 4-year survival rates in adult patients with pulmonary arterial hypertension associated with congenital heart disease","author":"Vis","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib119","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.recesp.2011.04.016","article-title":"Long-term (5 years) effects of bosentan in patients with pulmonary arterial hypertension","volume":"64","author":"Avellana","year":"2011","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib120","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.amjcard.2011.07.006","article-title":"Efficacy and safety of bosentan for pulmonary arterial hypertension in adults with congenital heart disease","volume":"108","author":"Monfredi","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib121","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ahj.2007.06.003","article-title":"Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist?","volume":"154","author":"van Loon","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2012.04.002_bib122","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1161\/CIRCULATIONAHA.107.742510","article-title":"Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2","volume":"117","author":"Galie","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2012.04.002_bib123","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.jacc.2009.07.033","article-title":"Long-term ambrisentan therapy for the treatment of pulmonary arterial hypertension","volume":"54","author":"Oudiz","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib124","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.amjcard.2010.12.051","article-title":"Ambrisentan for pulmonary arterial hypertension due to congenital heart disease","volume":"107","author":"Zuckerman","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib125","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1378\/chest.08-1028","article-title":"Ambrisentan therapy in patients with pulmonary arterial hypertension who discontinued bosentan or sitaxsentan due to liver function test abnormalities","volume":"135","author":"McGoon","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.hfc.2012.04.002_bib126","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Galie","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2012.04.002_bib127","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijcard.2006.10.018","article-title":"Effects of chronic sildenafil in patients with Eisenmenger syndrome versus idiopathic pulmonary arterial hypertension","volume":"120","author":"Chau","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib128","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ijcard.2006.10.017","article-title":"Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship","volume":"120","author":"Garg","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib129","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1161\/CIRCULATIONAHA.104.473371","article-title":"Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study","volume":"111","author":"Humpl","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2012.04.002_bib130","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijcard.2006.06.045","article-title":"Sildenafil therapy for pulmonary arterial hypertension associated with atrial septal defects","volume":"118","author":"Lim","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib131","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ehj.2004.01.013","article-title":"Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects","volume":"25","author":"Mikhail","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2012.04.002_bib132","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.105.603001","article-title":"Phosphodiesterase-5 inhibitor in Eisenmenger syndrome: a preliminary observational study","volume":"114","author":"Mukhopadhyay","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2012.04.002_bib133","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ahj.2005.09.006","article-title":"A\u00a0randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension","volume":"151","author":"Singh","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2012.04.002_bib134","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/01.CIR.99.14.1858","article-title":"Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects","volume":"99","author":"Rosenzweig","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2012.04.002_bib135","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0002-9149(02)03328-3","article-title":"Usefulness of epoprostenol therapy in the severely ill adolescent\/adult with Eisenmenger physiology","volume":"91","author":"Fernandes","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib136","doi-asserted-by":"crossref","first-page":"56S","DOI":"10.1016\/j.jacc.2004.02.036","article-title":"Prostanoid therapy for pulmonary arterial hypertension","volume":"43","author":"Badesch","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib137","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.healun.2004.02.004","article-title":"Reversal of pulmonary hypertension and subsequent repair of atrial septal defect after treatment with continuous intravenous epoprostenol","volume":"24","author":"Frost","year":"2005","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.hfc.2012.04.002_bib138","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1164\/ajrccm.165.6.2106079","article-title":"Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial","volume":"165","author":"Simonneau","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hfc.2012.04.002_bib139","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0735-1097(03)00463-7","article-title":"Beraprost therapy for pulmonary arterial hypertension","volume":"41","author":"Barst","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib140","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/S0735-1097(02)01786-2","article-title":"Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial","volume":"39","author":"Galie","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib141","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1378\/chest.126.2.420","article-title":"Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease","volume":"126","author":"Oudiz","year":"2004","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.hfc.2012.04.002_bib142","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijcard.2010.10.051","article-title":"Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology","volume":"155","author":"D'Alto","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib143","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1183\/09031936.05.00075305","article-title":"Goal-oriented treatment and combination therapy for pulmonary arterial hypertension","volume":"26","author":"Hoeper","year":"2005","journal-title":"Eur Respir J"},{"issue":"Suppl 3","key":"10.1016\/j.hfc.2012.04.002_bib144","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2362.2006.01692.x","article-title":"First experience with an oral combination therapy using bosentan and sildenafil for pulmonary arterial hypertension","volume":"36","author":"Lunze","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.hfc.2012.04.002_bib145","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1164\/rccm.200603-358OC","article-title":"Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension","volume":"174","author":"McLaughlin","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hfc.2012.04.002_bib146","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/01.crd.0000181618.29506.1e","article-title":"Use of long-term combined therapy with inhaled iloprost and oral sildenafil in an adult patient with eisenmenger syndrome","volume":"13","author":"Okyay","year":"2005","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.hfc.2012.04.002_bib147","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.109.898122","article-title":"Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)","volume":"122","author":"Benza","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2012.04.002_bib148","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1747-0803.2007.00104.x","article-title":"Pulmonary arterial hypertension associated with a congenital heart defect: advanced medium-term medical treatment stabilizes clinical condition","volume":"2","author":"Duffels","year":"2007","journal-title":"Congenit Heart Dis"},{"key":"10.1016\/j.hfc.2012.04.002_bib149","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/CIRCULATIONAHA.109.883876","article-title":"Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension","volume":"121","author":"Dimopoulos","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2012.04.002_bib150","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0272-5231(05)70293-8","article-title":"Lung transplantation for primary pulmonary hypertension","volume":"22","author":"Trulock","year":"2001","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.hfc.2012.04.002_bib151","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/S0003-4975(01)03099-5","article-title":"Heart-lung transplantation for Eisenmenger syndrome: early and long-term results","volume":"72","author":"Stoica","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.hfc.2012.04.002_bib152","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1053-2498(01)00420-X","article-title":"Heart-lung or lung transplantation for Eisenmenger syndrome","volume":"21","author":"Waddell","year":"2002","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.hfc.2012.04.002_bib153","doi-asserted-by":"crossref","first-page":"73S","DOI":"10.1016\/j.jacc.2004.02.039","article-title":"Interventional and surgical modalities of treatment for pulmonary arterial hypertension","volume":"43","author":"Klepetko","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib154","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1161\/CIRCULATIONAHA.107.734921","article-title":"Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease","volume":"117","author":"Dimopoulos","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2012.04.002_bib155","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijcard.2008.02.004","article-title":"Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy","volume":"129","author":"Dimopoulos","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib156","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s11886-009-0045-5","article-title":"Pulmonary hypertension complicating congenital heart disease","volume":"11","author":"Rame","year":"2009","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.hfc.2012.04.002_bib157","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1747-0803.2011.00611.x","article-title":"Can \u201cinoperable\u201d congenital heart defects become operable in patients with pulmonary arterial hypertension? Dream or reality?","volume":"7","author":"Beghetti","year":"2012","journal-title":"Congenit Heart Dis"},{"key":"10.1016\/j.hfc.2012.04.002_bib158","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/0002-8703(65)90328-5","article-title":"The hemodynamics in ventricular septal defect in childhood","volume":"70","author":"Kidd","year":"1965","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2012.04.002_bib159","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0735-1097(84)80187-4","article-title":"Primary surgical closure of ventricular septal defect in the first year of life: results in 128 infants","volume":"3","author":"Yeager","year":"1984","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib160","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/0002-9149(91)90284-R","article-title":"Late results (30 to 35 years) after operative closure of isolated ventricular septal defect from 1954 to 1960","volume":"68","author":"Moller","year":"1991","journal-title":"Am J\u00a0Cardiol"},{"key":"10.1016\/j.hfc.2012.04.002_bib161","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0002-9149(89)90340-8","article-title":"Assessment and follow-up of patients with ventricular septal defect and elevated pulmonary vascular resistance","volume":"63","author":"Neutze","year":"1989","journal-title":"Am J Cardiol"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713612000268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713612000268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T20:25:06Z","timestamp":1687551906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713612000268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":161,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S1551713612000268"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2012.04.002","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}